Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial. (Record no. 21990730)

MARC details
000 -LEADER
fixed length control field 01658 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516104011.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201303s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1468-2060
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1136/annrheumdis-2012-202071
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Pollard, Rodney P E
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20130306
245 00 - TITLE STATEMENT
Title Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Annals of the rheumatic diseases
Date of publication, distribution, etc. Jan 2013
300 ## - PHYSICAL DESCRIPTION
Extent 146-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Letter; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Murine-Derived
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antirheumatic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element B-Cell Activating Factor
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enzyme-Linked Immunosorbent Assay
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rituximab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sjogren's Syndrome
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Necrosis Factor Ligand Superfamily Member 13
General subdivision blood
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Abdulahad, Wayel H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vissink, Arjan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hamza, Nishath
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Burgerhof, Johannes G M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Meijer, Jiska M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Visser, Annie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Huitema, Minke G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Spijkervet, Fred K L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kallenberg, Cees G M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bootsma, Hendrika
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kroese, Frans G M
773 0# - HOST ITEM ENTRY
Title Annals of the rheumatic diseases
Related parts vol. 72
-- no. 1
-- p. 146-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1136/annrheumdis-2012-202071">https://doi.org/10.1136/annrheumdis-2012-202071</a>
Public note Available from publisher's website

No items available.